Drug Type Antibody |
Synonyms |
Target |
Mechanism SLC3A2 inhibitors(solute carrier family 3 member 2 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |